|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51949647
線上人數 :
807
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"parikh a"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2023 |
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
|
Camidge, D.R.;Barlesi, F.;Goldman, J.W.;Morgensztern, D.;Heist, R.;Vokes, E.;Spira, A.;Angevin, E.;Su, W.-C.;Hong, D.S.;Strickler, J.H.;Motwani, Motwani M.;Dunbar, M.;Parikh, A.;Noon, E.;Blot, V.;Wu, J.;Kelly, Kelly K. |
| 臺大學術典藏 |
2022-09-15T01:08:44Z |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano A.; Cassier P.A.; Chia-Chi Lin; Alanko T.; Peltola K.J.; Gazzah A.; Shiah H.-S.; Calvo E.; Cervantes A.; Roda D.; Tosi D.; Gao B.; Millward M.; Warburton L.; Tanner M.; Englert S.; Lambert S.; Parikh A.; Afar D.E.; Vosganian G.; Moreno V. |
| 臺大學術典藏 |
2020-05-25T07:35:09Z |
Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891
|
Powderly J; Cassier P.A; Cervantes A; Gao B; Gazzah A; Italiano A; Chia-Chi Lin; Luke J.J; Moreno V; Peltola K; Rasco D; Spira A.I; Tanner M.M.E; Tosi D; Afar D; Englert S; Parikh A; Reddy A; Vosganian G; Tolcher A.W. |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
